Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.

Summary

This study is designed to determine if the investigational drug is effective and safe in individuals with asthma

Timeline

Start

2007-12

Primary completion

2008-09

Completion

2008-09

Outcome

Met primary endpoint

registry Placebo vs GW642444M 12.5 µg; p = 0.011; Mean Difference (Final Values) 0.130 (95% CI 0.030 to 0.230) NCT00600171 ↗

Publications

• Background Lotvall J, Bateman ED, Bleecker ER, Busse WW, Woodcock A, Follows R, Lim J, Stone S, Jacques L, Haumann B. 24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids. Eur Respir J. 2012 Sep;40(3):570-9. doi: 10.1183/09031936.00121411. Epub 2012 Feb 23.

Drugs

Indications